Our study contributes to understand the potential contribution of apoA-I and apoB to the pathogenesis of ischemic stroke subtypes and highlights the potential clinical relevance of the apoB/apoA-I ratio in ICAS risk stratification and stenosis severity. Here, APOB is linked to familial isolated congenital asplenia.